Novozymes A/S (CPH:NSIS.B)

Novozymes Revenue

Novozymes had revenue of 1.12B EUR in the quarter ending March 31, 2026, with 3.87% growth. This brings the company's revenue in the last twelve months to 4.20B, up 3.49% year-over-year. In the year 2025, Novozymes had annual revenue of 4.16B with 8.45% growth.

• Revenue (ttm): 4.20B EUR
• Revenue Growth: +3.49%
• P/S Ratio: 5.69
• Revenue / Employee: 372.84K EUR
• Employees: 11,263
• Market Cap: 178.58B DKK

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.16B	324.10M	8.45%
Dec 31, 2024	3.83B	1.43B	59.58%
Dec 31, 2023	2.40B	46.92M	1.99%
Dec 31, 2022	2.36B	344.63M	17.14%
Dec 31, 2021	2.01B	122.03M	6.46%
Dec 31, 2020	1.89B	-34.05M	-1.77%
Dec 31, 2019	1.92B	-460.00K	-0.02%
Dec 31, 2018	1.92B	-28.45M	-1.46%
Dec 31, 2017	1.95B	44.04M	2.31%
Dec 31, 2016	1.91B	28.53M	1.52%
Dec 31, 2015	1.88B	204.34M	12.20%
Dec 31, 2014	1.67B	99.58M	6.32%
Dec 31, 2013	1.58B	69.01M	4.58%
Dec 31, 2012	1.51B	92.11M	6.51%
Dec 31, 2011	1.41B	109.59M	8.40%
Dec 31, 2010	1.30B	166.75M	14.66%
Dec 31, 2009	1.14B	44.95M	4.11%
Dec 31, 2008	1.09B	92.14M	9.21%
Dec 31, 2007	1.00B	88.28M	9.68%
Dec 31, 2006	912.26M	70.85M	8.42%
Dec 31, 2005	841.41M	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error